Table 1. Baseline characteristics of the phase I cohort.
| Variables | n | % |
| Sex | ||
| Male | 150 | 53.6 |
| Female | 130 | 46.4 |
| Age at diagnosis | ||
| Median | 68.42 years (range:25.29–91.61) | |
| Grade | ||
| Poorly differentiated/undifferentiated | 42 | 15 |
| Well/moderately differentiated | 234 | 83.6 |
| Unknown | 4 | 1.4 |
| Histology | ||
| Mucinous | 43 | 15.4 |
| Non-mucinous | 237 | 84.6 |
| Location | ||
| Rectum | 57 | 20.4 |
| Colon | 223 | 79.6 |
| Lymphatic invasion of tumor | ||
| Lymphatic invasion (+) | 110 | 39.3 |
| Lymphatic invasion (−) | 70 | 25 |
| Unknown | 100 | 35.7 |
| Stage | ||
| I | 54 | 19.3 |
| II | 94 | 33.6 |
| III | 76 | 27.1 |
| IV | 47 | 16.8 |
| Unknown | 9 | 3.2 |
| MSI status | ||
| MSI-H | 34 | 12.1 |
| MSS/MSI-L | 246 | 87.9 |
| Prognostic and follow up information | ||
| OS status at the time of last follow up | ||
| Dead | 172 | 61.4 |
| Alive | 108 | 38.6 |
| Median OS and DSS (follow up) time | 5.31 years (range: 0–12.52) | |
| DFS status at the time of last follow up | ||
| Recurrence/metastasis/death (+) | 184 | 65.7 |
| Recurrence/metastasis/death (−) | 96 | 34.3 |
| DFS (follow up) time | 3.37 years (range: 0–12.52) | |
| DSS status at the time of last follow up | ||
| Death from colorectal cancer | 113 | 40.4 |
| Death from other causes or alive | 167 | 59.6 |
(+): present, (−): absent, DFS: disease free survival, DSS: disease specific survival, MSI-H: microsatellite instability-high, MSI-L: microsatellite instability-low, MSS: microsatellite stable, OS: overall survival.